Navigation Links
New AMITIZA 8 mcg Phase III Studies Demonstrated Overall Symptom Improvement in Adult Women with Irritable Bowel Syndrome with Constipation (IBS-C)
Date:5/18/2008

a from Two

Multicenter, Randomized, Placebo-

controlled Trials

S1272 Lubiprostone is Effective and Well Poster; Sunday, May

Tolerated Through 48 Weeks of 18, 2008 from 8am-

Treatment in Adults with Irritable 5pm PDT; Poster

Bowel Syndrome and Constipation presentation from

12pm-2pm PDT

T1036 Health-Related Quality of Life in Poster; Tuesday,

Adults with Irritable Bowel Syndrome May 20, 2008 from

with Constipation: Results of a 8am-5pm PDT; Poster

Combined Analysis of Two Phase 3 presentation from

Studies with Lubiprostone 12pm-2pm PDT

M1706 Discontinuation of Lubiprostone Poster; Monday, May

Treatment for Irritable Bowel Syndrome 19, 2008 from 8am-

with Constipation is Not Associated 5pm PDT; Poster

with Symptom Increase or Recurrence: presentation from

Results from a randomized withdrawal 12pm-2pm PDT

study

Abstract Presentation

Number Abstract Title Type/Date/Time

Outcomes Data

T1029 Development of an Instrument to Assess Poster; Tuesday,

Treatment Satisfaction in Patients May 20, 2008 from

with Chronic Constipation 8am-5pm PDT; Poster

presentation from

12pm-2pm PDT

T1030 Similarities between Constipation with Poster; Tuesday,

and without Irritable Bowel Syndrome May 20, 2008 from

in a California Medicaid (Medi-Cal) 8am-5pm PDT; Poster

<
'/>"/>
SOURCE Takeda Pharmaceuticals North America, Inc.; SucampoPharmaceuticals,
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis
2. Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials
3. BioVex to Report Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting
4. GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab)
5. Cerenis Therapeutics Completes Phase I Clinical Trial of CER-002 for Treatment of Cardiovascular Disease
6. Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial
7. VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial
8. Progen Resumes Phase 1 Development of Anti-Cancer Agent, PG-11047
9. Biopure Announces Publication of Phase II Proof-of-Concept Coronary Trial
10. NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc.
11. Velcura Therapeutics, Inc. Reports Successful Phase 1 Clinical Trial of Novel Bone Disease Therapy

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...GO,Nov.23/PRNewswire/--TwooftheChicagoarea,sleadin...ganewerainwomen,sbreastimaging,couplingthelatestte...ticultrasoundwiththeabilitytohavethefullrangeofdig...atientbeforesheleavestheoffice.Drs.AhmedFaragandJo...withoutthecurrent6-9monthwaitforanappointmentcommo...
(Date:11/23/2009)...K,Mass.,Nov.23/PRNewswire-FirstCall/--BostonScient...einthePiperJaffrayHealthCareConference,December1-2...erandSamLeno,ExecutiveVicePresidentandChiefFinanci...uttheCompanyonTuesday,December1st,beginningatappro...ssionwillbeavailabletoallinterestedpartiesatBoston...
(Date:11/23/2009)...RICHMOND,Calif.,Nov.23/PRNewswire-FirstCall/--Tran...ncedthatitisscheduledtomeetwiththeU.S.FoodandDrugA...leteResponseLetterregardingtheNewDrugApplication(N...ualtablet).Aspreviouslyannounced,theCompleteRespon...atedthattheFDAcouldnotapprovetheNDAinitspresentfor...
Breaking Medicine Technology:Transcept Pharmaceuticals Scheduled to Meet With FDA to Discuss Intermezzo(R) Complete Response Letter 2Hispanic Dental Association and Oral Health America Celebrate National Smile Month June 1 30 47633 1Hispanic Dental Association and Oral Health America Celebrate National Smile Month June 1 30 47633 2New One Year Data from REMICADE 28R 29 SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohns Disease 4518 1New One Year Data from REMICADE 28R 29 SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohns Disease 4518 2New One Year Data from REMICADE 28R 29 SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohns Disease 4518 3New One Year Data from REMICADE 28R 29 SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohns Disease 4518 4New One Year Data from REMICADE 28R 29 SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohns Disease 4518 5New One Year Data from REMICADE 28R 29 SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohns Disease 4518 6New One Year Data from REMICADE 28R 29 SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohns Disease 4518 7New One Year Data from REMICADE 28R 29 SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohns Disease 4518 8New One Year Data from REMICADE 28R 29 SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohns Disease 4518 9Three New ZonePerfect 28R 29 Dark Chocolate Nutrition Bar Flavors Fuel Satisfying and Delicious Snacking 47625 1Three New ZonePerfect 28R 29 Dark Chocolate Nutrition Bar Flavors Fuel Satisfying and Delicious Snacking 47625 2Three New ZonePerfect 28R 29 Dark Chocolate Nutrition Bar Flavors Fuel Satisfying and Delicious Snacking 47625 3Three New ZonePerfect 28R 29 Dark Chocolate Nutrition Bar Flavors Fuel Satisfying and Delicious Snacking 47625 4
..., Data Being Presented Today at 44th Annual Meetin... and Program Status During Q1 Financial Results Ca...Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ) tod...ional non-nucleoside polymerase inhibitor, demonst... and was well tolerated in a Phase Ib study in whi...
..., ST. LOUIS, April 23 SAFC Biosciences(R), a busi...-Aldrich Group (Nasdaq: SIAL ), today announced ...th and viral production media designed exclusively...) duck cells used in the commercial production of ...-CELL EBx media is expected to further enable EB6...
Other Medicine Technology:ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 2ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 3ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 4ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 5ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 6ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 7ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 8SAFC Biosciences(R) and Vivalis Collaborate to Optimize Cell Culture Media for Vaccines Production 2SAFC Biosciences(R) and Vivalis Collaborate to Optimize Cell Culture Media for Vaccines Production 3SAFC Biosciences(R) and Vivalis Collaborate to Optimize Cell Culture Media for Vaccines Production 4SAFC Biosciences(R) and Vivalis Collaborate to Optimize Cell Culture Media for Vaccines Production 5
(Date:11/23/2009)... Same Day STD Testing now pr...s for all types of STD,s, including Chlamydia, Her...-- all done anonymously. , ...g found on the web at: http://www.samedaystdtesti...ential STD testing, which is now available to accu...
(Date:11/23/2009)..., ActingSecretaryEncouragesUseofPAPreferredProd...ewswire-USNewswire/--Toensurethatyourfamilyhasasaf...ryRussellReddingisurgingresidentstofollowafewbasic...vers. ,, "Followingandunderstandingproperfoodha...ingsureyourThanksgivingdinnerissafetoeat,"saidRedd...
(Date:11/23/2009)...iomethylation of arsenic compounds appears to caus...nogenicity, according to a new study published onl...ncer Institute . , Although biomethylation was o...now thought to enhance its toxicity and potentiall... arsenic biomethylation in oxidative DNA damage in...
(Date:11/23/2009)...EW YORK (Nov. 23, 2009) -- A first-of-its-kind con...online today in the Annals of Surgery . The repor...nal consensus conference -- Diabetes Surgery Summi...an 50 scientific and medical experts agreed on a s...at are meant to guide the use and study of gastroi...
(Date:11/23/2009)... Bernadine Healy, first woman to head the agency, ...Nov. 23 (HealthDay News) -- The fallout from last ...ay the start of routine mammogram testing for brea.... National Institutes of Health advising women to ...fully ignore them, because unequivocally this will...
Breaking Medicine News(10 mins):Health News:100% Anonymous, Confidential and Quick STD Screening Now Available with Same Day STD Testing 2Health News:Pennsylvania Agriculture Department Encourages Proper Food Handling, Offers Safety Tips for Thanksgiving 2Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 2Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 3Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 4Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 5Health News:Women Should Ignore New Mammogram Guideline, Ex-NIH Chief Says 2Health News:Women Should Ignore New Mammogram Guideline, Ex-NIH Chief Says 3
...O ALTO, Calif., March 31 Varian, Inc.,(NasdaqGS: ...0 GC Series, a,new family of high performance gas ...olutions. The 400 Series consists of two gas chrom...w chemists,and engineers to employ standard method...
...One group of small, non-coding RNA molecules could...ay also be able to convert some advanced tumors to...cago-based research team in the April 1, 2008, iss... When normal cells are transformed into cancer cel...
...HINGTON, March 31 Survival rates of,childhood can...n the past,three decades, but survivors of this di... challenges as young adults. Depending on the exte...rding to a,study prepublished online in Blood, the...
...NTAIN VIEW, Calif., March 31 Alexza,Pharmaceutica...has obtained a,committed equity financing facility...registered common stock to Azimuth Opportunity, Lt...ty and,debt financing transactions., "This flexib...
...nge from Coaching to Consulting Addresses Fears Th...ss And Most Accurately Describes The Business, WA...ated, http://www.attorneyweightloss.com, today a...t in the,nation executive weight loss coaching ser...
...EI PROVINCE, China, March 31 /Xinhua-PRNewswire-Fi...in Board: BPMA), a China-based,pharmaceutical comp...gene,therapy medicine for the treatment of cancer,... The Company plans to file,its Annual Report with ...
Other Medicine News:Health News:New High Performance Gas Chromatographs and Analysis Solutions From Varian, Inc. Offer Enhanced Performance and Capabilities for More Applications 2Health News:New High Performance Gas Chromatographs and Analysis Solutions From Varian, Inc. Offer Enhanced Performance and Capabilities for More Applications 3Health News:Replacing absent microRNAs could make tumors less invasive, more treatable 2Health News:Replacing absent microRNAs could make tumors less invasive, more treatable 3Health News:Childhood Leukemia Survivors Struggle With Long-Term Comorbidities 2Health News:Childhood Leukemia Survivors Struggle With Long-Term Comorbidities 3Health News:Childhood Leukemia Survivors Struggle With Long-Term Comorbidities 4Health News:Alexza Secures $50 Million Committed Equity Financing Facility With Azimuth Opportunity, Ltd. 2Health News:Alexza Secures $50 Million Committed Equity Financing Facility With Azimuth Opportunity, Ltd. 3Health News:Alexza Secures $50 Million Committed Equity Financing Facility With Azimuth Opportunity, Ltd. 4Health News:Leventhal Weight Loss Incorporated Becomes First in the Nation Executive Weight Loss Consulting Service for Attorneys by an Attorney 2Health News:Benda Pharmaceutical Reports Fourth Quarter and Full Year 2007 Financial Results 2Health News:Benda Pharmaceutical Reports Fourth Quarter and Full Year 2007 Financial Results 3Health News:Benda Pharmaceutical Reports Fourth Quarter and Full Year 2007 Financial Results 4Health News:Benda Pharmaceutical Reports Fourth Quarter and Full Year 2007 Financial Results 5Health News:Benda Pharmaceutical Reports Fourth Quarter and Full Year 2007 Financial Results 6Health News:Benda Pharmaceutical Reports Fourth Quarter and Full Year 2007 Financial Results 7Health News:Benda Pharmaceutical Reports Fourth Quarter and Full Year 2007 Financial Results 8Health News:Benda Pharmaceutical Reports Fourth Quarter and Full Year 2007 Financial Results 9Health News:Benda Pharmaceutical Reports Fourth Quarter and Full Year 2007 Financial Results 10
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
Medicine Products: